You are here

Article Text

Article menu
Download PDFPDF
Short report
A case of inclusion body myositis with benign monoclonal gammopathy successfully responding to repeated immunoabsorption
  1. T Nakayamaa,
  2. E Horiuchia,
  3. T Watanabea,
  4. S Murayamab,
  5. H Nakasea
  1. aDepartment of Neurology, Toranomon Hospital, 2–2–2, Toranomon, Minato-ku, Tokyo 105–8470, Japan, bDepartment of Neurology, Division of Neuroscience, Graduate school of Medicine, University of Tokyo, 7–3–1, Hongo, Bunkyo-ku, Tokyo 113–0033, Japan
  1. Dr H Nakase, Department of Neurology, Toranomon Hospital, 2–2–2, Toranomon, Minato-ku, Tokyo 105–8470, Japan emailnakase-tky{at}umin.ac.jp

Abstract

A 69 year old woman with inclusion body myositis is described. She presented with benign monoclonal gammopathy. She was resistant to steroid therapy, but responded to repeated immunoabsorption. Up to now, there has been no established therapy for inclusion body myositis, including IVIg. It is suggested that immunoabsorption could be an alternative therapy for inclusion body myositis, when it was accompanied by immunological abnormality.

  • inclusion body myositis
  • benign monoclonal gammopathy
  • steroid therapy
  • immunoabsorption
  • IgG

https://doi.org/10.1136/jnnp.68.2.230

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes